NO20031743L - Krystallinsk venlafaxinbase og nye polyformer av venlafaxin- hydroklorid, samt fremgangsmåte for fremstilling derav - Google Patents

Krystallinsk venlafaxinbase og nye polyformer av venlafaxin- hydroklorid, samt fremgangsmåte for fremstilling derav

Info

Publication number: NO20031743L
Authority: NO; Norway
Prior art keywords: venlafaxine; polyforms; novel; preparation; crystalline
Prior art date: 2000-10-19

Application number

NO20031743A

Other languages

English (en)

Norwegian (no)

Other versions

NO20031743D0 (no

Inventor

Ben-Zion Dolitzky

Judith Aronhime

Shlomit Wizel

Gennady Nisnevish

Original Assignee

Teva Pharma

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-10-19

Filing date

2003-04-15

Publication date

2003-06-18

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27500045&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20031743(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2003-04-15 Application filed by Teva Pharma filed Critical Teva Pharma

2003-04-15 Publication of NO20031743D0 publication Critical patent/NO20031743D0/no

2003-06-18 Publication of NO20031743L publication Critical patent/NO20031743L/no

Links

229960004688 venlafaxine Drugs 0.000 title 1
PNVNVHUZROJLTJ-UHFFFAOYSA-N venlafaxine Chemical compound C1=CC(OC)=CC=C1C(CN(C)C)C1(O)CCCCC1 PNVNVHUZROJLTJ-UHFFFAOYSA-N 0.000 title 1
229960002416 venlafaxine hydrochloride Drugs 0.000 title 1
QYRYFNHXARDNFZ-UHFFFAOYSA-N venlafaxine hydrochloride Chemical compound [H+].[Cl-].C1=CC(OC)=CC=C1C(CN(C)C)C1(O)CCCCC1 QYRYFNHXARDNFZ-UHFFFAOYSA-N 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C215/00—Compounds containing amino and hydroxy groups bound to the same carbon skeleton
- C07C215/42—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having amino groups or hydroxy groups bound to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C213/00—Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton
- C07C213/10—Separation; Purification; Stabilisation; Use of additives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
- C07C217/54—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
- C07C217/74—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with rings other than six-membered aromatic rings being part of the carbon skeleton
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
- C07C2601/14—The ring being saturated

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Pain & Pain Management (AREA)
Psychiatry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

NO20031743A 2000-10-19 2003-04-15 Krystallinsk venlafaxinbase og nye polyformer av venlafaxin- hydroklorid, samt fremgangsmåte for fremstilling derav NO20031743L (no)

Applications Claiming Priority (5)

Application Number	Priority Date	Filing Date	Title
US24157700P	2000-10-19	2000-10-19
US25886100P	2000-12-29	2000-12-29
US27872101P	2001-03-26	2001-03-26
US29246901P	2001-05-21	2001-05-21
PCT/US2001/051017 WO2002045658A2 (en)	2000-10-19	2001-10-19	Crystalline venlafaxine base and novel polymorphs of venlafaxine hydrochloride, processes for preparing thereof

Publications (2)

Publication Number	Publication Date
NO20031743D0 NO20031743D0 (no)	2003-04-15
NO20031743L true NO20031743L (no)	2003-06-18

Family

ID=27500045

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20031743A NO20031743L (no)	2000-10-19	2003-04-15	Krystallinsk venlafaxinbase og nye polyformer av venlafaxin- hydroklorid, samt fremgangsmåte for fremstilling derav

Country Status (20)

Country	Link
US (1)	US20020143211A1 (zh)
EP (1)	EP1334082A4 (zh)
JP (2)	JP2004530638A (zh)
KR (1)	KR20030059206A (zh)
CN (1)	CN1620420A (zh)
AU (1)	AU2002241764A1 (zh)
CA (1)	CA2426158A1 (zh)
CZ (1)	CZ20031298A3 (zh)
DE (1)	DE01988460T1 (zh)
ES (1)	ES2206082T1 (zh)
HR (1)	HRP20030392A2 (zh)
HU (1)	HUP0303496A3 (zh)
IL (2)	IL155400A0 (zh)
IS (1)	IS6789A (zh)
MX (1)	MXPA03003459A (zh)
NO (1)	NO20031743L (zh)
PL (1)	PL365895A1 (zh)
SK (1)	SK5762003A3 (zh)
WO (1)	WO2002045658A2 (zh)
YU (1)	YU30203A (zh)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US20020183553A1 (en) *	2000-10-19	2002-12-05	Ben-Zion Dolitzky	Crystalline venlafaxine base and novel polymorphs of venlafaxine hydrochloride, processes for preparing thereof
AU2002212340B2 (en)	2000-10-31	2006-12-14	Sandoz Ag	Crystalline forms of venlafaxine hydrochloride
HUP0104872A3 (en) *	2001-11-13	2004-04-28	Egis Gyogyszergyar Nyilvanosan	New polymorphic forms of venlafaxine, process for their preparation, pharmaceutical compositions containing them and their use
UA77234C2 (en) *	2001-12-05	2006-11-15	Wyeth Corp	Monohydrate of venlafaxine hydrochloride and methods for its preparation (variants)
RU2004120285A (ru) *	2001-12-05	2005-04-10	Уайт (Us)	Новый кристаллический полиморф гидрохлорида венлафаксина и способы его получения
AU2002247945A1 (en) *	2001-12-13	2003-06-23	Cadila Healthcare Limited	Manufacture of venlafaxine hydrochloride and crystalline polymorphs thereof
AU2003226751A1 (en)	2002-03-28	2003-10-13	Synthon B.V.	Low water-soluble venlafaxine salts
AR039163A1 (es)	2002-03-28	2005-02-09	Synthon Bv	Besilato de venlafaxina
US20030190352A1 (en) *	2002-03-28	2003-10-09	Synthon Bv	Compositions of venlafaxine base
DE10359154A1 (de) *	2003-12-16	2005-07-28	Krka Tovarna Zdravil, D.D.	Verfahren zur Herstellung von Venlafaxin und Venlafaxinhydrochlorid der Form I
US7468428B2 (en)	2004-03-17	2008-12-23	App Pharmaceuticals, Llc	Lyophilized azithromycin formulation
US7544841B2 (en) *	2004-10-20	2009-06-09	Mitsubishi Tanabe Pharma Corporation	Production method of phenylethanolamine compound, and its intermediate
KR20080056311A (ko) *	2005-10-19	2008-06-20	테바 파마슈티컬 인더스트리즈 리미티드	고순도1-[2-디메틸아미노-(4-메톡시페닐)에틸)시클로헥산올염산염의 제조 방법
WO2007049302A2 (en) *	2005-10-28	2007-05-03	Ind-Swift Laboratories Limited	An improved process for the preparation of pure venlafaxine
EP2436381A1 (en)	2006-06-27	2012-04-04	Sandoz AG	Crystallization of hydrohalides of pharmaceutical compounds
EP2081885A2 (en) *	2006-07-14	2009-07-29	Medichem, S.A.	Improved processes for preparing venlafaxine base and salts thereof
CN103025705B (zh) *	2010-10-01	2014-01-22	山东绿叶制药有限公司	4-甲基苯甲酸4-[2-二甲基胺基-1-（1-羟基环己基）乙基]苯酯盐酸盐的多晶型物、制备方法及其应用
AR099354A1 (es)	2013-11-15	2016-07-20	Akebia Therapeutics Inc	Formas sólidas de ácido {[5-(3-clorofenil)-3-hidroxipiridin-2-carbonil]amino}acético, composiciones, y sus usos

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4535186A (en) *	1983-04-19	1985-08-13	American Home Products Corporation	2-Phenyl-2-(1-hydroxycycloalkyl or 1-hydroxycycloalk-2-enyl)ethylamine derivatives
US4611078A (en) *	1983-10-26	1986-09-09	American Home Products Corporation	Substituted phenylacetonitriles
AR255595A1 (zh)	1994-07-13	2002-05-24	Gador Sa
PE57198A1 (es) *	1996-03-25	1998-10-10	American Home Prod	Formula de liberacion prolongada
US6197828B1 (en) *	1998-12-01	2001-03-06	Sepracor, Inc.	Derivatives of (+)-venlafaxine and methods of preparing and using the same
US20020183553A1 (en) *	2000-10-19	2002-12-05	Ben-Zion Dolitzky	Crystalline venlafaxine base and novel polymorphs of venlafaxine hydrochloride, processes for preparing thereof
AU2002212340B2 (en)	2000-10-31	2006-12-14	Sandoz Ag	Crystalline forms of venlafaxine hydrochloride
WO2002046140A1 (en)	2000-12-07	2002-06-13	Dr. Reddy's Laboratories Ltd.	Novel crystalline polymorphic forms of venlafaxine hydrochloride and a process for their preparation

2001
- 2001-10-19 KR KR10-2003-7005447A patent/KR20030059206A/ko not_active Application Discontinuation
- 2001-10-19 SK SK576-2003A patent/SK5762003A3/sk not_active Application Discontinuation
- 2001-10-19 IL IL15540001A patent/IL155400A0/xx unknown
- 2001-10-19 EP EP01988460A patent/EP1334082A4/en not_active Withdrawn
- 2001-10-19 CZ CZ20031298A patent/CZ20031298A3/cs unknown
- 2001-10-19 CN CNA018208185A patent/CN1620420A/zh active Pending
- 2001-10-19 DE DE0001334082T patent/DE01988460T1/de active Pending
- 2001-10-19 WO PCT/US2001/051017 patent/WO2002045658A2/en active Application Filing
- 2001-10-19 AU AU2002241764A patent/AU2002241764A1/en not_active Abandoned
- 2001-10-19 HU HU0303496A patent/HUP0303496A3/hu unknown
- 2001-10-19 ES ES01988460T patent/ES2206082T1/es active Pending
- 2001-10-19 US US10/045,510 patent/US20020143211A1/en not_active Abandoned
- 2001-10-19 YU YU30203A patent/YU30203A/sh unknown
- 2001-10-19 PL PL01365895A patent/PL365895A1/xx not_active Application Discontinuation
- 2001-10-19 CA CA002426158A patent/CA2426158A1/en not_active Abandoned
- 2001-10-19 MX MXPA03003459A patent/MXPA03003459A/es unknown
- 2001-10-19 JP JP2002547444A patent/JP2004530638A/ja active Pending
2003
- 2003-04-15 IS IS6789A patent/IS6789A/is unknown
- 2003-04-15 NO NO20031743A patent/NO20031743L/no not_active Application Discontinuation
- 2003-05-15 HR HR20030392A patent/HRP20030392A2/hr not_active Application Discontinuation
2008
- 2008-04-30 JP JP2008119070A patent/JP2008239629A/ja active Pending
- 2008-12-31 IL IL196287A patent/IL196287A0/en unknown

Also Published As

Publication number	Publication date
AU2002241764A1 (en)	2002-06-18
NO20031743D0 (no)	2003-04-15
IL196287A0 (en)	2011-08-01
DE01988460T1 (de)	2004-04-22
YU30203A (sh)	2006-08-17
IL155400A0 (en)	2003-11-23
CZ20031298A3 (cs)	2003-10-15
WO2002045658A3 (en)	2003-01-16
ES2206082T1 (es)	2004-05-16
IS6789A (is)	2003-04-15
JP2008239629A (ja)	2008-10-09
HUP0303496A2 (hu)	2004-01-28
MXPA03003459A (es)	2005-04-29
KR20030059206A (ko)	2003-07-07
HUP0303496A3 (en)	2005-08-29
HRP20030392A2 (en)	2005-04-30
EP1334082A4 (en)	2006-02-01
WO2002045658A2 (en)	2002-06-13
SK5762003A3 (en)	2003-11-04
PL365895A1 (en)	2005-01-10
EP1334082A2 (en)	2003-08-13
CA2426158A1 (en)	2002-06-13
CN1620420A (zh)	2005-05-25
US20020143211A1 (en)	2002-10-03
JP2004530638A (ja)	2004-10-07

Similar Documents

Publication	Publication Date	Title
NO20031743L (no)	2003-06-18	Krystallinsk venlafaxinbase og nye polyformer av venlafaxin- hydroklorid, samt fremgangsmåte for fremstilling derav
NO20042932L (no)	2004-07-12	En ny polymorf form av sertralin-hydroklorid og preparater som inneholder denne, samt nye fremgangsmater for fremstilling av polymorfe former og en amorf form av sertralinhydroklorid
NO20005454L (no)	2000-12-07	Nye hydroksyindoler, deres anvendelse som fosfodiesterase 4 inhibitorer og fremgangsmåte for fremstilling derav
NO20031694L (no)	2003-04-11	Krystallinsk monohydrat, fremgangsmåte for fremstilling derav og anvendelsederav til fremstilling av et medikament
NO20040680L (no)	2004-02-16	Nye dihydropterinonerfremgangsmate for fremstilling derav og deres anvendelse som legemiddel
DK1373224T3 (da)	2007-10-15	Nye spirotricykliske derivater og deres anvendelse som phosphodiesterase 7 inhibitorer
IL162253A0 (en)	2005-11-20	Venlafaxine hydrochloride monohydrate and methods for the preparation thereof
IL149222A0 (en)	2002-11-10	Stable polymorph of n-(3-ethynlamino)-6,7-bis (2-metoxyethoxy)- 4-quinaolinamine hydrochloride, methods of production, and pharmaceutical uses thereof
NO20015113L (no)	2001-12-19	Nye forbindelser, deres fremstilling og anvendelse
NO20035696D0 (no)	2003-12-19	Krystallinsk anti-cholinergikum, fremgangsmåte for fremstilling derav og anvendelse derav til fremstilling av et legemiddel
EE04234B1 (et)	2004-02-16	L-fenüülefriinvesinikkloriidi valmistamise meetod
AP2004002989A0 (en)	2004-03-31	Novel crystalline polymorphic forms of lercanidipine hydrochloride and process for their preparation.
ITUD20000163A0 (it)	2000-09-05	Dispositivo per la produzione di manufatti poliuretanici, relativo procedimento e manufatti poliuretanici cosi' ottenuti
AU1234002A (en)	2002-05-15	Crystalline forms of venlafaxine hydrochloride
IS7289A (is)	2004-05-27	Kristallaður venlafaxínbasi og nýir fjölgervingarvenlafaxínhýdróklóríðs, aðferðir til að framleiðaþá
NO20015058L (no)	2001-12-17	Nye ribose-substituerte aromatiske amider, fremgangsmåte for deres fremstilling og deres anvendelse som legemidler
DK1098891T3 (da)	2005-12-12	Polycycliske thiazolidin-2-yliden-aminer, fremgangsmåde til fremstilling deraf og deres anvendelse som lægemidler
IL162255A0 (en)	2005-11-20	Novel crystalline polymorph of venlafaxine hydrochloride and methods for the preparation thereof
IL159266A0 (en)	2004-06-01	Crystalline forms of fexofenadine and processes for the preparation thereof
ZA200405245B (en)	2007-01-31	Venlafaxine hydrochloride monohydrate and methods for the preparation thereof
NO20040479L (no)	2004-02-03	Solvater av lerkanidipinhydroklorid og nye krystallinske former av lerkanidipinhydroklorid.
DK1265856T3 (da)	2004-07-05	Hidtil ukendt fremgangsmåde til fremstillingen af alpha-(2,4-disulfophenyl)-N-tert-butylnitron og farmaceutisk acceptable salte deraf
NO20014077L (no)	2001-10-24	Fremgangsmåte for krystallisering av N-(4-trifluormetylfenyl)- 5-metyl-isoksazol-4-karboksamid
DK1373232T3 (da)	2006-03-27	Fremgangsmåde til fremstilling af N-substituerede 2,6-dialkylmorpholiner
NO20040426L (no)	2004-03-26	Nye imidazolidinderivater og deres fremstilling og andvendelse som VLA-4-antagonister.

Legal Events

Date	Code	Title	Description
2006-05-29	FC2A	Withdrawal, rejection or dismissal of laid open patent application